Developmental/Behavioral Disorders

Latest News

FDA grants RPDD to CSTI-500 for treating pediatric Prader-Willi Syndrome | Image Credit: © wladimir1804 - © wladimir1804 - stock.adobe.com.
FDA grants RPDD to CSTI-500 for treating pediatric Prader-Willi Syndrome

July 25th 2024

ConSynance Therapeutics' CSTI-500, an innovative Triple Monoamine Reuptake Inhibitor, has received FDA's Rare Pediatric Disease Designation for treating Prader-Willi Syndrome in children.

Cerliponase alfa FDA approved to slow loss of ambulation in children of all ages with CLN2 disease | Image Credit: © Calin - © Calin - stock.adobe.com.
Cerliponase alfa FDA approved to slow loss of ambulation in children of all ages with CLN2 disease

July 25th 2024

Toddler tablet use may hinder attentive, behavioral development
Toddler tablet use may hinder attentive, behavioral development

July 12th 2024

Screening tool identifies kids at high risk for reading disorders | Image Credit: Contemporary Pediatrics
Screening tool identifies kids at high risk for reading disorders

June 24th 2024

Early childhood genetic testing for global developmental delay could reduce misdiagnosis rate | Image Credit: © Cavan - © Cavan - stock.adobe.com.
Early childhood genetic testing for global developmental delay could reduce misdiagnosis rate

June 10th 2024

More News

© 2024 MJH Life Sciences

All rights reserved.